Early diagnosis and intervention for prepubertal short stature children

GOU Peng; CHENG Xin-Ran

doi:10.7499/j.issn.1008-8830.2312103

PDF(588 KB)

Chinese Journal of Contemporary Pediatrics ›› 2024, Vol. 26 ›› Issue (6) : 553-558. DOI: 10.7499/j.issn.1008-8830.2312103

SERIES LECTURE—STANDARDIZED DIAGNOSIS AND TREATMENT OF SHORT STATURE IN CHILDREN

Early diagnosis and intervention for prepubertal short stature children

GOU Peng, CHENG Xin-Ran

Author information +

History +

Abstract

The prevalence of short stature among prepubertal children in China is relatively high. Early identification of the cause and timely intervention can bring greater benefits to children with short stature. This paper provides an overview of early diagnosis, intervention measures, and personalized medication dosage for prepubertal short stature children, aiming to provide references for clinical doctors.

Key words

Short stature / Prepubertal / Early diagnosis / Early intervention / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

GOU Peng, CHENG Xin-Ran. Early diagnosis and intervention for prepubertal short stature children[J]. Chinese Journal of Contemporary Pediatrics. 2024, 26(6): 553-558 https://doi.org/10.7499/j.issn.1008-8830.2312103

References

1 Polidori N, Castorani V, Mohn A, et al. Deciphering short stature in children[J]. Ann Pediatr Endocrinol Metab, 2020, 25(2): 69-79. PMID: 32615685. PMCID: PMC7336267. DOI: 10.6065/apem.2040064.032.
2 中华医学会儿科学分会内分泌遗传代谢学组. 矮身材儿童诊治指南[J]. 中华儿科杂志, 2008, 46(6): 428-430. PMID: 19099778. DOI: 10.3321/j.issn:0578-1310.2008.06.007.
3 秦原, 杨禄红. 武汉市儿童矮小症患病率调查及病因分析[J]. 中国妇幼保健, 2017, 32(14): 3306-3310.
4 Stagi S, Scalini P, Farello G, et al. Possible effects of an early diagnosis and treatment in patients with growth hormone deficiency: the state of art[J]. Ital J Pediatr, 2017, 43(1): 81. PMID: 28915901. PMCID: PMC5603037. DOI: 10.1186/s13052-017-0402-8.
5 Li F, Liu K, Zhao Q, et al. Prevalence of short stature among children in China: a systematic review[J]. Pediatr Investig, 2021, 5(2): 140-147. PMID: 34179712. PMCID: PMC8212717. DOI: 10.1002/ped4.12233.
6 Huang S, Chen Z, Chen R, et al. Analysis of risk factors and construction of a prediction model for short stature in children[J]. Front Pediatr, 2022, 10: 1006011. PMID: 36561487. PMCID: PMC9763591. DOI: 10.3389/fped.2022.1006011.
7 Safari O, Ejtahed HS, Namazi N, et al. Association of short stature and obesity with cardio-metabolic risk factors in Iranian children and adolescents: the CASPIAN-V study[J]. J Diabetes Metab Disord, 2021, 20(2): 1137-1144. PMID: 34900767. PMCID: PMC8630324. DOI: 10.1007/s40200-021-00831-1.
8 陈凌华, 赵慧, 张素珍, 等. 矮小症儿童主观生活质量和社会适应能力的研究[J]. 中国儿童保健杂志, 2016, 24(12): 1271-1273. DOI: 10.11852/zgetbjzz2016-24-12-11.
9 中华人民共和国国家卫生健康委员会. 7岁以下儿童生长标准: WS/T 423-2022[S]. 北京: 中国标准出版社, 2022.
10 中华医学会儿科学分会内分泌遗传代谢学组, 中华医学会儿科学分会儿童保健学组, 中华儿科杂志编辑委员会. 儿童体格发育评估与管理临床实践专家共识[J]. 中华儿科杂志, 2021, 59(3): 169-174. PMID: 33657689. DOI: 10.3760/cma.j.cn112140-20210116-00050.
11 奚立, 罗飞宏. 从内分泌激素角度审视身材矮小的评估[J]. 中国实用儿科杂志, 2021, 36(8): 581-585. DOI: 10.19538/j.ek2021080605.
12 Rogol AD, Hayden GF. Etiologies and early diagnosis of short stature and growth failure in children and adolescents[J]. J Pediatr, 2014, 164(5 Suppl): S1-S14.e6. PMID: 24731744. DOI: 10.1016/j.jpeds.2014.02.027.
13 李辉. 再论儿童生长发育的科学评估[J]. 中国儿童保健杂志, 2021, 29(6): 581-583. DOI: 10.11852/zgetbjzz2021-0771.
14 中华医学会儿科学分会内分泌遗传代谢学组, 《中华儿科杂志》编辑委员会, 梁雁. 基因重组人生长激素儿科临床规范应用的建议[J]. 中华儿科杂志, 2013, 51(6): 426-432. PMID: 24120059. DOI: 10.3760/cma.j.issn.0578-1310.2013.06.007.
15 Yang-Li D, Fei-Hong L, Hui-Wen Z, et al. Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China[J]. Orphanet J Rare Dis, 2022, 17(1): 221. PMID: 35698200. PMCID: PMC9195308. DOI: 10.1186/s13023-022-02302-z.
16 Zenker M, Edouard T, Blair JC, et al. Noonan syndrome: improving recognition and diagnosis[J]. Arch Dis Child, 2022, 107(12): 1073-1078. PMID: 35246453. PMCID: PMC9685729. DOI: 10.1136/archdischild-2021-322858.
17 Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society[J]. J Clin Endocrinol Metab, 2000, 85(11): 3990-3993. PMID: 11095419. DOI: 10.1210/jcem.85.11.6984.
18 Collett-Solberg PF, Ambler G, Backeljauw PF, et al. Diagnosis, genetics, and therapy of short stature in children: a growth hormone research society international perspective[J]. Horm Res Paediatr, 2019, 92(1): 1-14. PMID: 31514194. PMCID: PMC6979443. DOI: 10.1159/000502231.
19 Kim JH, Chae HW, Chin SO, et al. Diagnosis and treatment of growth hormone deficiency: a position statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology[J]. Endocrinol Metab (Seoul), 2020, 35(2): 272-287. PMID: 32615711. PMCID: PMC7386113. DOI: 10.3803/EnM.2020.35.2.272.
20 潘慧, 班博, 于萍, 等. 从临床诊疗指南及专家共识角度看重组人生长激素治疗的规范化应用[J]. 中华诊断学电子杂志, 2014, 2(2): 85-89. DOI: 10.3877/cma.j.issn.2095-655X.2014.02.001.
21 Grimberg A, DiVall SA, Polychronakos C, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency[J]. Horm Res Paediatr, 2016, 86(6): 361-397. PMID: 27884013. DOI: 10.1159/000452150.
22 Al Shaikh A, Daftardar H, Alghamdi AA, et al. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center[J]. Acta Biomed, 2020, 91(1): 29-40. PMID: 32191651. PMCID: PMC7569569. DOI: 10.23750/abm.v91i1.9182.
23 Chaplin JE, Kristr?m B, Jonsson B, et al. Improvements in behaviour and self-esteem following growth hormone treatment in short prepubertal children[J]. Horm Res Paediatr, 2011, 75(4): 291-303. PMID: 21304250. DOI: 10.1159/000322937.
24 Maghnie M, Orso M, Polistena B, et al. Quality of life in children and adolescents with growth hormone deficiency and their caregivers: an Italian survey[J]. J Endocrinol Invest, 2023, 46(12): 2513-2523. PMID: 37209402. PMCID: PMC10632207. DOI: 10.1007/s40618-023-02106-3.
25 林丹, 冯海英. 重组人生长激素联合营养及运动干预用于特发性矮小症的效果[J]. 中国现代医生, 2022, 60(15): 1-3.
26 何肖华, 马华梅, 李燕虹, 等. 长效生长激素治疗青春期前生长激素缺乏症的疗效分析[J]. 中山大学学报（医学科学版）， 2020, 41(6): 981-990. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2020.0129.
27 Hou L, Huang K, Gong C, et al. Long-term pegylated GH for children with GH deficiency: a large, prospective, real-world study[J]. J Clin Endocrinol Metab, 2023, 108(8): 2078-2086. PMID: 36669772. PMCID: PMC10348466. DOI: 10.1210/clinem/dgad039.
28 Lackner L, Quitmann JH, Witt S. Caregiving burden and special needs of parents in the care of their short-statured children: a qualitative approach[J]. Front Endocrinol (Lausanne), 2023, 14: 1093983. PMID: 37008922. PMCID: PMC10064859. DOI: 10.3389/fendo.2023.1093983.
29 孙颖, 冯海英, 叶建敏, 等. 心理干预对矮小症儿童心理状态和生活质量的影响[J]. 中国现代医生, 2018, 56(17): 50-53.
30 Mahfuz M, Alam MA, Das S, et al. Daily supplementation with egg, cow milk, and multiple micronutrients increases linear growth of young children with short stature[J]. J Nutr, 2020, 150(2): 394-403. PMID: . DOI: 10.1093/jn/nxz253.
31 Zhang Z, Li F, Hannon BA, et al. Effect of oral nutritional supplementation on growth in children with undernutrition: a systematic review and meta-analysis[J]. Nutrients, 2021, 13(9): 3036. PMID: 34578914. PMCID: PMC8468927. DOI: 10.3390/nu13093036.
32 Sun F, Chao L, Zhang J, et al. Exercise combined with lysine-inositol vitamin B12 promotes height growth in children with idiopathic short stature[J]. Growth Horm IGF Res, 2023, 69-70: 101535. PMID: 37245296. DOI: 10.1016/j.ghir.2023.101535.
33 段利侠, 李婷, 牛忠鹏. 认知行为疗法在矮小症儿童治疗中的应用及对儿童SDS、SAS评分的影响[J]. 临床与病理杂志, 2021, 41(11): 2638-2643. DOI: 10.3978/j.issn.2095-6959.2021.11.023.
34 王懿. 表扬艺术联合合理情绪疗法对学龄矮小症患儿自我认同感及生存质量的影响研究[J]. 中国医学创新, 2021, 18(5): 77-81. DOI: 10.3969/j.issn.1674-4985.2021.05.020.
35 Cohen P, Weng W, Rogol AD, et al. Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerations[J]. Clin Endocrinol (Oxf), 2014, 81(1): 71-76. PMID: 24428305. PMCID: PMC4160145. DOI: 10.1111/cen.12408.
36 Chen J, Zhong Y, Wei H, et al. Polyethylene glycol recombinant human growth hormone in Chinese prepubertal slow-growing short children: doses reported in a multicenter real-world study[J]. BMC Endocr Disord, 2022, 22(1): 201. PMID: 35945517. PMCID: PMC9364582. DOI: 10.1186/s12902-022-01101-8.
37 Jiang Z, Chen X, Dong G, et al. Short-term efficacy and safety of a lower dose of polyethylene glycol recombinant human growth hormone in children with growth hormone deficiency: a randomized, dose-comparison study[J]. Front Pharmacol, 2022, 13: 955809. PMID: 36034802. PMCID: PMC9402941. DOI: 10.3389/fphar.2022.955809.
38 Sun C, Lu B, Liu Y, et al. Reduced effectiveness and comparable safety in biweekly vs. weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency: a phase IV non-inferiority threshold targeted trial[J]. Front Endocrinol (Lausanne), 2021, 12: 779365. PMID: 34899612. PMCID: PMC8655095. DOI: 10.3389/fendo.2021.779365.